Medindia LOGIN REGISTER
Medindia
Blue Blood of Horseshoe Crabs - A Silent Partner Who Ensures Vaccine Safety

Blue Blood of Horseshoe Crabs - A Silent Partner Who Ensures Vaccine Safety

by Saisruthi Sankaranarayanan on Aug 25 2021 4:02 PM
Listen to this article
0:00/0:00

Highlights:
  • Limulus Amoebocyte Lysate (LAL), derived from the blood of horseshoe crabs is used in testing the safety of pharmaceutical products
  • Increases in the need for vaccines also increases the demand for LAL, leading to the risk of extinction of horseshoe crabs
  • A man-made version of LAL called Recombinant Factor C (rFC) had been found already, although not widely accepted by the healthcare industry
Vaccines are the “superweapons” that protect us from many kinds of diseases, including the recently emerged SARS-CoV-2 infection. While the hard work of researchers behind the vaccine development is huge, there is one other silent partner that ensured vaccine safety: The blood of horseshoe crabs.

Advertisement

What Kind of Creatures are Horseshoe Crabs?

Horseshoe crabs are helmet-shaped creatures that can grow as large as 20 inches. This is because they used to predate the dinosaurs, a time when everything was large, around more than 300 million years. They are closely related to scorpions and spiders and thrive on the brackish floors of coastal waters.
Horseshoe crabs can fluoresce under ultraviolet light. Their eggs are considered a primary fat source for more than a dozen species of migratory shore birds, according to South Carolina's Department of Natural Resources. What's more important is their blood!

Advertisement

How Does the Blood of Horseshoe Crabs Serve to Scientific Community?

The endotoxins released by bacteria have the potential to induce inflammation and fever and can cause anaphylactic shock and death. They can also cause venereal disease, bacterial meningitis as well as cholera, bubonic plague and other diseases. The copper-rich bright blue blood of horseshoe crabs contains immune cells that trap and immobilize these bacterial toxins. This kept the crabs alive for about 450 million years.

By making use of the components present in these clever blood cells, scientists developed a compound called Limulus Amoebocyte Lysate, or LAL and since 1970s, it is helping medical professionals giving out jabs devoid of bad bacteria that could make humans sick. It also helps ensure that biomedical devices are contaminant-free.While this seems incredible, conservationists slam the use of crab’s blood.

Advertisement

Here’s the Story Behind the Life Struggle of Horseshoe Crabs

The harvesting of these crabs is concerned mainly with the coast of South Carolina. This is because Governor Henry McMaster thought it would not be good to depend on foreign countries for pharma needs and have companies like Charles River Laboratories, top-producer of Limulus Amoebocyte Lysatein from horseshoe blood in the United States would be fine.

But conservationists had a different opinion and accused the U.S. Fish and Wildlife Service as it allowed horseshoe crab harvesting in some wildlife areas including South Carolina's Cape Romain National Wildlife Refuge. After that there was a temporary halt in the harvest but soon, it resumed following Charles River's appeal.

In addition, the environmental groups have also been asked to withdraw their complaint within August 2021 as federal officials will be permitting commercial activities in the refuge, including horseshoe harvesting. Foster Jordan of Charles River Labs further adds that only 20% of their harvest comes from the refuge, while most coming from further down the South Carolina coast.

Pharmaceutical companies need to make sure each and every drug or vaccine candidate is contaminant-free. This makes LAL testing, a critical one. And, if all the drug companies continue to rely solely on LAL, horseshoe crab populations will be put at risk. The attempts to produce new and efficient vaccines against COVID-19 have further increased the need for horseshoe crabs and concerns about the sustainability of these creatures are rising.

Does Science Have Anything to Fix This Issue?

Using biotech manufacturing processes, it has been possible to produce the man-made version of LAL called Recombinant Factor C (rFC), which reduces potential impacts to the horseshoe crab community. It is a non-animal-derived reagent used to detect bacterial endotoxins in pharmaceutical products.

Last year, a group of researchers from Eli Lilly, Bristol Myers Squibb, Pfizer and ­Roche-Genentech published a research report that intended to compare the efficacy of two products limulus amebocyte lysate (LAL) made from horseshoe crab blood and recombinant Factor C (rFC), a synthetic product. The insights provided by the paper did little to publicize the use of this recombinant product.

While the synthetic alternatives to LAL are not widely accepted by the health care industry, Jordan also highlights, “My mission is to make sure that any competitor that comes into the United States, from China or any of these other producers, has to go through the same regulatory process that we had to go through, to make sure that it’s safe. If all these synthetics start coming in from other countries, we’re going to lose the protection that we’ve had for all these years, and the safety, and the control of the drug supply.”

Considering both the safety of ecosystem and increasing pharmaceutical needs across the globe, the issue seems like a house of cards, as the governor mentioned, where every other card falls if we pull out even one part of it. It is important to maintain a healthy balance between scientific demands and the planet's ecosystem to meet whatever requirements are there to protect any sort of life.

References:
  1. Horseshoe crab blood: the miracle vaccine ingredient that's saved millions of lives - (https://www.nhm.ac.uk/discover/horseshoe-crab-blood-miracle-vaccine-ingredient.html)
  2. Horseshoe Crab - (https://www.nwf.org/Educational-Resources/Wildlife-Guide/Invertebrates/Horseshoe-Crab)
  3. Bolden J, Knutsen C, Levin J, Milne C, Morris T, Mozier N, Spreitzer I, von Wintzingerode F. Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review. PDA J Pharm Sci Technol. 2020 Sep-Oct;74(5):602-611. doi: 10.5731/pdajpst.2020.012187. Epub 2020 Aug 14. PMID: 32817324.


Source-Medindia


Advertisement